Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 183, pseudogene (RNU6-183P)
- Target
- RNU6-183P
- Molecular classification
- Processed pseudogene, Small noncoding RNA pseudogene, Other (not a gene family with biological function)
01
Overview
RNU6-183P is a *processed pseudogene* copy of the U6 small nuclear RNA (snRNA) gene, present in the human genome due to retrotransposition, usually mediated by L1 retrotransposons[1][2]. Unlike the functional U6 snRNA, which is essential for splicing as part of the spliceosome machinery[3], processed pseudogenes such as RNU6-183P lack the regulatory sequences and structural integrity needed for biological function. They do not produce functional RNA or protein, and are generally considered “genomic fossils.” While pseudogenes can play regulatory or evolutionary roles by acting as RNA decoys or through gene conversion, there is no evidence of RNU6-183P contributing to such activity. In general, pseudogenes have low transcription levels, and their expression is rarely linked to disease states[1][2][4]. RNU6-183P is not a drug target, biomarker, or a molecular target for therapeutic intervention.
- Other names
- RNU6-183PRNA, U6 small nuclear 183, pseudogene
02
Mechanism of action
None — There are no known drugs or mechanisms of action targeting this pseudogene.
03
Biological functions
Other (no known biological function; pseudogenes generally do not encode functional products; U6 snRNA itself is central to pre-mRNA splicing, but pseudogenes do not usually retain these functions)
04
Disease associations
Other (no known direct disease role for RNU6-183P; however, some pseudogene expression patterns have been linked to cancer subtypes, though evidence is limited and not established for this specific pseudogene)
Beyond the preview
Go deeper on RNA, U6 small nuclear 183, pseudogene (RNU6-183P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 183, pseudogene (RNU6-183P).